Content by Keyword: Access or Barriers

PDF report
Current Estimates of Supply and Utilization of

Current Estimates of Supply and Utilization of Immune Globulin Products

In February 2007, the Eastern Research Group (ERG) submitted to the Office of the Assistant Secretary for Planning and Evaluation (ASPE) Analysis of Supply, Distribution, Demand, and Access Issues Associated with Immune Globulin Intravenous (IGIV) (2007 report).
  • IGIV_Market_Update.pdf
    export-csvPDF
PDF report
Experiences of Medicaid Programs and Health

Experiences of Medicaid Programs and Health Centers in Implementing Telehealth

Health centers are experimenting with telehealth for a range of conditions, working with different types of remote providers, and confronting different telehealth policies and implementation barriers, depending on their locations and payer mix.  This paper explores the experiences of health centers and state Medicaid programs in seven states.
  • Medicaid-Telehealth.pdf
    export-csvPDF
Report page
APPENDIX F: National Drug Codes Used to Identify

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. APPENDIX F: National Drug Codes Used to Identify Prescription Drug Fills for Substance Use Disorders in Preliminary Analysis

National Drug Code Product Name Use Dosage in MG 00456-3330-01 CAMPRAL AUD 333
Report page
APPENDIX E: Supplemental Regression Analyses

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. APPENDIX E: Supplemental Regression Analyses Results

Annual Descriptive Trends and Simple Regression Analysis We produced annual outcome trends for the average and 95thpercentile for all service categories, comparing non-BH, MH, and SUD diagnosis groups as well as OUD and non-OUD SUD trends. We then produced plotted graphs to visually assess whether there were distinct patterns in results or disco
Report page
APPENDIX D: Prescription Drug National Drug Codes

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. APPENDIX D: Prescription Drug National Drug Codes Used to Identify Opioid Use Disorder Subpopulation

NDC Prod_Name Route of Admin Master Form Code Strength in MG Generic Name
Report page
APPENDIX C: Mental Health and Substance Use

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. APPENDIX C: Mental Health and Substance Use Disorder Diagnosis Codes

ICD-9-CM Diagnosis Code Description of ICD-9-CM Diagnosis Code MH or SUD Diagnosis Group Related CCS Category 3090 Adjustment disorder with depressed mood
Report page
APPENDIX B: Methods

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. APPENDIX B: Methods

Introduction The purpose of this appendix is to provide additional details on the methodology and analytic approach used in the study to obtain the results presented in the main section of the report. This includes details on specific codes used in data from the MarketScan CCAE Database, such as International Classification of Diseases, Ninth Re
Report page
APPENDIX A: Definitions of Acronyms and

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. APPENDIX A: Definitions of Acronyms and Abbreviations

Acronym Definition ASAM American Society of Addiction Medicine ASPE HHS Office of the Assistant Secretary for Planning and Evaluation AUD Alcohol Use Disorder
Report page
NOTES

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. NOTES

Stuart EA, McGinty EE, Kalb L, et al. Increased service use among children with autism spectrum disorder associated with Mental Health Parity Law. Health Affairs. 2017; 36(2): 337-345. For more information on the federal rulemaking process refer to: https://www.federalregister.gov/uploads/2011/01/the_rulemaking_process.pdf .
Report page
5. CONCLUSIONS

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. 5. CONCLUSIONS

MHPAEA Had a Positive Impact on Utilization of Outpatient Behavioral Health Services at the Mean
Report page
4. RESULTS

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. 4. RESULTS

We divide our results into several sections: Utilization Outcomes . Average Insurer and Enrollee Spending Outcomes . Insurer Reimbursement and Enrollee Out-of-Pocket Outcomes . Out-of-Network Outcomes . Outcomes for Service Utilizers at the 95th Percentile and Subpopulations .
Report page
3. METHODS

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. 3. METHODS

Study Period Our period of study was from January 2005 through September 2015. We selected these years to have an adequate number of pre-parity and post-parity months for analysis.[ 28 ] Within the full study period, we defined three separate time periods to assess the impact of MHPAEA based on the timeline of MHPAEA's implementation:
Report page
2. BACKGROUND

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. 2. BACKGROUND

Efforts to ensure that individuals with BH conditions receive insurance benefits that are comparable to those with medical conditions have been unfolding over the course of the past two decades. Two federal parity laws have been passed that directly apply to large group health plans.
Report page
1. INTRODUCTION

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. 1. INTRODUCTION

The Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) ensures that large group health plans and health insurance issuers offer comparable benefits for mental health (MH) and substance use disorder (SUD) services and medical/surgical services. This legislation builds on prior federal parity legislation
Report page
EXECUTIVE SUMMARY

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. EXECUTIVE SUMMARY

Background
Report page
ABSTRACT

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. ABSTRACT

Summary : The Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) ensures that large group health plans and health insurance issuers offer comparable benefits for mental health (MH) and substance use disorder (SUD) services and medical/surgical services.
Report page
STANDARD ABSTRACT

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. STANDARD ABSTRACT

This study assessed the impact of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) on the private, large group employer-sponsored insurance market. The impact of MHPAEA on mental health (MH) and substance use disorder (SUD) utilization and spending outcomes was assessed using interrupted time seri
Report page
ACKNOWLEDGMENTS

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report. ACKNOWLEDGMENTS

Truven Health Analytics, an IBM company, prepared this report under contract to the Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services (HHS) (HHSP233201600023I/HHSP23337002T). The authors appreciate the guidance of D.E.B. Potter and Laurel Fuller (ASPE), Emily Jones (National Institut
Report
Assessing the Impact of Parity in the Large Group

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report

Norah Mulvaney-Day, Brent Gibbons, and Shums Alikhan TruvenHealth Analytics, an IBM company February 2019 Printer Friendly Version in PDF Format (111 PDF pages)
PDF report
Assessing the Impact of Parity in the Large Group

Assessing the Impact of Parity in the Large Group Employer-Sponsored Insurance Market: Final Report

ABSTRACT
  • LGParity.pdf
    export-csvPDF

Pages